Last $3.78 USD
Change Today -0.19 / -4.79%
Volume 129.7K
NBS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 12:35 PM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Edmund K. Waller M.D., Ph.D., FACP

Member of Amorcyte Scientific Advisory Board, Neostem, Inc.
AgeTotal Calculated CompensationThis person is connected to 52 board members in 3 different organizations across 3 different industries.

See Board Relationships
----

Background*

Dr. Edmund K. Waller, M.D., Ph.D., FACP, is an Associate Professor of Medicine and Director, Bone Marrow & Transplant Center Winship Cancer Institute Emory University. Dr. Waller is also a Professor of Medicine, hematology/Oncology and Pathology at aEmory University School of Medicine in Atlanta, Georgia. He serves as Medical Director for the Stem Cell Processing Laboratory, Hemapheresis Department, and Clinical Trials Office of the Winship Cancer Institute. Dr. Waller ...

Read Full Background

Corporate Headquarters*

420 Lexington Avenue
New York, New York 10170

United States

Phone: 212-584-4180
Fax: 646-514-7787

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Doctorate
Rockefeller University
MD
Cornell University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NBS:US $3.78 USD -0.19

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Dominick C. Colangelo Esq.Chief Executive Officer, President, Treasurer and Director
Vericel Corporation
$358.3K
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$568.8K
Robin C. Stracey Interim Chief Executive Officer, Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Governance & Nominating Committee
Cesca Therapeutics Inc.
--
Marc H. Hedrick M.D.Chief Executive Officer, President and Director
Cytori Therapeutics, Inc.
$406.6K
Martin M. McGlynn Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc
StemCells Inc.
$835.8K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOSTEM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.